Bladder Cancer

September 24, 2020

The positive findings could make nivolumab the new standard of care in the adjuvant setting for patients with muscle-invasive urothelial cancer.

September 24, 2020

The antibody-drug conjugate enfortumab vedotin significantly improved overall survival versus chemotherapy in a phase 3 trial.

September 23, 2020

Pivotal phase 3 trial launched to confirm promising results in metastatic urothelial carcinoma.

September 17, 2020

Of 2463 patients with urothelial cancer who underwent comprehensive genomic profiling, 39% harbored ≥1 tier 1-2 genomic alterations.

September 14, 2020

“The grasper disposable scope may fill the gap as an alternative to the conventional reusable cystoscope,” researchers concluded.

September 14, 2020

Tele-cystoscopy was found equivalent to traditional cystoscopy with respect to identification of abnormalities and action decisions.

August 26, 2020

Differences following surgery were related to the control of cancer and adjustments with urinary diversion.

August 25, 2020

"Therapeutic strategies are needed in the management of NMIBC that recurs after gold-standard intravesical BCG," Gomella writes.

August 20, 2020

Investigators warn of the dangers of overprescribing antibiotics in cancer care.

August 18, 2020

The new dose would reduce a patient’s required medical visits by 50%.

August 14, 2020

Increased usage of bladder diagrams was observed following implementation of the program.

August 07, 2020

Including the genomic test in the protocol for patient surveillance reduced the average number of annual cystoscopies by approximately 39%.

August 04, 2020

The cost-savings are particularly noteworthy given prior evidence of blue light imaging enhancing the efficacy of diagnostic cystoscopy.

July 31, 2020

A multidisciplinary panel outlines criteria for stratifying risk for genitourinary malignancy in patients with microhematuria.

July 24, 2020

Intravesical Oncofid P-B, a conjugate of paclitaxel and hyaluronic acid, is active in patients with carcinoma in situ of the bladder that is not responsive to bacillus Calmette-Guérin.

July 24, 2020

Given the efficacy and safety demonstrated, there may be a role going forward for the pembrolizumab/nab-paclitaxel combination in earlier disease stages.

July 17, 2020

Intravesical instillations prevent recurrence of non–muscle-invasive bladder cancer.

July 15, 2020

The study compared regimens for patients with high-risk non–muscle invasive bladder cancer.

July 14, 2020

72.9% of patients with papillary disease achieved high-grade recurrence-free survival at 3 months after initial treatment.

July 08, 2020

Cabozantinib's single-agent activity opens the potential for combination approaches with immunotherapy in patients with heavily pretreated urothelial carcinoma.